About
An experienced and accomplished senior executive in the life sciences industry; e.g…
Articles by Dr. Irit
-
VP of Clinical & Regulatory
VP of Clinical & Regulatory
One of Accelmed's successful portfolio company is seeking for a VP of Clinical & Regulatory So, if you have a track…
5 Comments -
IATI Biomed 2015
IATI Biomed 2015
IATI-Biomed 2015, the premier international Biomed Conference and Exhibition in Israel, will take place between May…
2 Comments
Activity
12K followers
-
Dr. Irit Yaniv shared thisI'm speaking at #LSIEurope26, September 28th to October 1st, in Barcelona. LSI is the global industry leader in medtech, and LSI Europe ’26 is the next stop on their global circuit where the world’s top emerging companies, investors, and strategics come to innovate, invest, and connect in Europe. If you're attending, I'd love to connect. Message me in the app or on LinkedIn. @LSI Europe @LSI #LSIEurope26
-
Dr. Irit Yaniv shared thisI'll be speaking on “Pitch Perfect: How to Tell a Story Investors Believe” on the La Valette Stage on Day 1 (12 November). If you're attending, come say hello. I'd love to hear what you're working on, exchange ideas and continue the conversation over a coffee. Mediterranean Conference Centre, Valletta, Malta 11–13 November 2026 #MedTechWorldEurope #MTWEurope2026 #MedTechWorld #MedTech #Healthcare #LifeSciences #Malta #Valletta #Europe
-
Dr. Irit Yaniv reposted thisA defining day for Momentis Surgical. Today’s FDA clearance for multiport surgery establishes Anovo as the first robotic platform with regulatory clearance across natural orifice, single-port/single-site, and multiport approaches. It’s an important validation of our platform architecture and a major step toward our vision of delivering a more capable, compact, and economically accessible robotic surgery system. I’m incredibly proud of our team and grateful to the surgeons, hospital partners, and investors who have believed in this mission. The opportunity ahead is tremendous, and we’re excited for what’s next.Dr. Irit Yaniv reposted thisA Major Milestone for the Future of Robotic Surgery. Today marks an exciting day for the entire team at Momentis Surgical™. The FDA has granted 510(k) clearance for the multiport configuration of the Anovo® Surgical System, making Anovo the first robotic platform capable of supporting all three surgical approaches on a single flexible robotic platform: ✅ Natural Orifice Surgery ✅ Single-Port Surgery ✅ Multiport Surgery This is far more than another regulatory milestone—it represents a fundamental shift in how robotic surgery can be delivered. For the first time, surgeons have the flexibility to choose the optimal surgical approach for each patient without requiring multiple robotic systems. Hospitals and ASCs can now offer greater capabilities with a single compact platform, while benefiting from a smaller footprint, simplified workflow, and a compelling economic model. Our proprietary flexible robotic architecture—with internally articulated shoulder-, elbow-, and wrist-like instruments—continues to challenge the limitations of conventional robotic systems by delivering true 360° dexterity while minimizing external robotic arm movement. Congratulations to every engineer, clinician, regulatory professional, manufacturing specialist, and team member whose passion and relentless commitment made this achievement possible. This is another important step toward expanding patient access to robotic surgery and empowering surgeons with technology designed around clinical flexibility—not limitations. The future of robotic surgery isn't about one approach. It's about giving surgeons the freedom to choose the best approach for every patient. Congratulations, Team Momentis! The journey is just getting started. #MomentisSurgical #Anovo #RoboticSurgery #FDA #MedicalDevices #MedTech #GeneralSurgery #Gynecology #MinimallyInvasiveSurgery #Innovation #HealthcareInnovation #ASC #Surgery https://lnkd.in/dUR7xxanFDA Clears Momentis Surgical's Anovo® System for Multiport Surgery, Making It the First Robotic Platform to Support Three Surgical ApproachesFDA Clears Momentis Surgical's Anovo® System for Multiport Surgery, Making It the First Robotic Platform to Support Three Surgical Approaches
-
Dr. Irit Yaniv shared thisAn amazing oppertunity!Dr. Irit Yaniv shared thisThe Stage is Set for $1,500,000 investment! Iron Nation is launching a unique Startup Competition to back the next wave of scale-ready Israeli innovation, with a $1.5M investment awarded to the winner! Why Apply? $1.5M Investment: Capital to fuel your journey. Exclusive Access: Pitch live to our Managing Partners, LPs, and top investors. Global Visibility: Take the stage at our flagship annual investor conference at Startup Nation Central. U.S. Launchpad: Get a fast track to Iron Nation’s infrastructure built for scaling into the U.S. market. Who should apply? Israel-related advanced technology startups with a proven product, initial traction, and a path to US scale. Applications are open from July 8th until August 15th. 👉 Link for more details in the comments below! Izhar Shay Chemi Peres Charlie Federman Dr. Irit Yaniv Nitsan Alon José Francisco Fernández Serna Startup Nation Central #DeepTech #VentureCapital #StartupCompetition
-
Dr. Irit Yaniv shared thisA great way to start the morning💪💪Dr. Irit Yaniv shared thisThis week, I had one of the best breakfasts. I had the opportunity to join this week’s intimate Breakfast Club, hosted at Dr. Irit Yaniv ‘s residence as part of the WE@HealthTech Cohort 7 Leadership Program. It was a meaningful morning filled with inspiring conversations, valuable insights, and genuine connections. Thank you for the opportunity to be part of such an empowering and enriching discussion. #WomenLeadership #WomenInHealth #WEHealthTech
-
Dr. Irit Yaniv reposted thisDr. Irit Yaniv reposted thisSee the PRECISION-GI™ EUS Motorized Biopsy Device in action. The PRECISION-GI™ Device uses a motorized rotational core biopsy mechanism with a familiar approach—designed to help collect high‑quality tissue with less blood using fewer activations to support histological and molecular profiling. Learn more: https://hubs.la/Q04ms4Tg0 #Endoscopy #AdvancedEndoscopy #EUS Only available in the U.S.
-
Dr. Irit Yaniv shared thisAn innovation that can help many women🙏 Edit Goldberg - Keep Going!Dr. Irit Yaniv shared thisAs Pelvic Organ Prolapse Awareness Month comes to a close, we want to recognize the millions of women living with pelvic organ prolapse (POP), many of whom suffer in silence. Pelvic organ prolapse affects nearly 1 in 2 women over the age of 50, yet too many women delay seeking treatment because they believe their symptoms are simply a normal part of aging or childbirth. They are not. Every woman deserves to know that effective treatment options are available—and every surgeon deserves access to innovative tools that can help improve procedural efficiency while delivering excellent patient care. At Escala Medical, our mission is to empower surgeons with technologies that simplify pelvic floor reconstruction and expand access to minimally invasive treatment options. While June may be ending, our commitment to improving the lives of women with pelvic floor disorders continues every day. Together, let's continue raising awareness, advancing innovation, and ensuring more women know they don't have to live with POP. #PelvicOrganProlapse #POPAwareness #WomensHealth #Urogynecology #PelvicFloor #MedicalInnovation #MedTech #EscalaMedical #Mendit
-
Dr. Irit Yaniv shared thisAssaf Klein - A well written articleDr. Irit Yaniv shared thisAn Israeli doctor looked at the way pancreatic cancer had been biopsied for 25 years, decided it wasn't good enough, and reinvented the needle. The crazy part? The idea came from a squash corer. Professor Iyad Khamaysi runs the advanced endoscopy unit at Rambam in Haifa, and for years he watched the same broken tool come back with the same useless sample. Pancreatic cancer is the deadliest major cancer there is, the only common one with a five-year survival rate still under 20%, and whether a patient gets a diagnosis at all comes down to one small piece of tissue. By his own account, in up to one in five cases that tissue came back too fragmented and bloody to read, and the patient went back under sedation to do it again. The tool that fetches that sample is cruder than you'd expect: a thin needle a doctor pushes in and out by hand, sometimes 30 to 50 stabs across several passes, deep inside the body. For a quarter-century the device industry attacked the problem by reshaping the tip of that needle. A new bevel. A fork. A three-sided crown. Brilliant engineering, all of it aimed at the point of a needle a human still had to shove by hand. Khamaysi stepped out of that contest. He looked at a squash corer, the kitchen tool that turns once and lifts out a clean cylinder, and built a needle that rotates instead of stabs. Then he put a motor on it, something no one in the field had done before. His device, Limaca Medical Ltd's Precision-GI, is the only motorized one there is. Where the old needle could take five passes and fifty stabs to bring back a smear, his takes a single pass and lifts out a clean core. What that motor really buys is consistency. A patient at a regional hospital now gets the same grade of sample as one at a flagship research center, because a machine doesn't have an off day. The FDA fast-tracked it and cleared it, Medicare covers it, and it's in American hospitals right now. The lung is next. Rambam, the Trendlines incubator and the Israel Innovation Authority all got behind him. The company's name, Limaca, is the old Greek word for a snail, for the spiral the needle carves. He just didn't want to send one more patient back for a second biopsy. That's not a coincidence. That's Israel. For the full piece: https://lnkd.in/dgtMUiUV
-
Dr. Irit Yaniv reposted thisDr. Irit Yaniv reposted thisWhen tissue quality and efficiency matter, early evidence suggests motorized EUS‑FNB may help. Reported outcomes from a 40‑patient evaluation utilizing the PRECISION-GI™ EUS Motorized Biopsy Device included: • 97.5% technical success and 95% adequate samples • Lower blood contamination: 25% vs 65% • Longer core fragments: 30% vs 15% (>10mm) • Liver biopsy: median 6 vs 2 portal triads Explore the clinical evidence and featured content here: https://hubs.la/Q04lR0c20 Only available in the U.S. #ClinicalEvidence #Endoscopy #EUS
Dr. Irit Yaniv commented on a post
1w
Well Done!!
-
Dr. Irit Yaniv liked thisDr. Irit Yaniv liked thisEdge Medical Ventures Managing Partner Gal Atarot had an in-depth conversation with Ashley Yeo of In Vivo, Citeline on how the unique Edge model enables us to build medtech companies around validated, critical clinical needs and set them up to succeed, by pairing R&D and innovation funding in Israel with US investment and hands-on go-to-market support. This could only be done with the support of our partners on both sides of the Atlantic, Israel Innovation Authority and New Jersey Economic Development Authority (NJEDA). As Ashley explains, Edge "leverages the twin powers of an Israel innovation hub and US hands-on operational, clinical, regulatory and reimbursement efforts." Edge continues to work alongside its companies, such as Synchrony Medical, Exero Medical, Urologic Health, as a "C-suite plug-in," from the first clinical need through regulatory, reimbursement and commercial launch, as we aim to build category-leading medtech companies that improve patient care, creating as the article refers to it "A small and efficient factory for manufacturing companies." Read the full piece here: https://lnkd.in/dYCyEa2U
-
Dr. Irit Yaniv liked thisDr. Irit Yaniv liked this#ASTRO26 is two days away. Join the GammaTile team at 12 PM this Sunday, September 27th, for an Industry Expert Theater, “Improved Local Control and Survival: Phase 3 Evidence for Tile-Based Radiation in Brain Metastases.” Add to calendar: https://lnkd.in/gW6_-AQF Brandon Imber, MD, MA, is an Assistant Attending Radiation Oncologist at Memorial Sloan Kettering Cancer Center. Lindsey Sloan, MD, PhD, is an Associate Professor in Radiation Oncology and a radiobiologist at the Masonic Cancer Center. She leads the Sloan Laboratory within the University of Minnesota Brain Tumor Program and serves on the faculty of the University of Minnesota Medical School. See full prescribing information at https://lnkd.in/gkXeVbtE
-
Dr. Irit Yaniv liked thisDr. Irit Yaniv liked thisRapid Medical’s Tigertriever 17 Ultra Receives CE Mark Approval for Stroke Treatment https://lnkd.in/gUVdGs_SRapid Medical’s Tigertriever 17 Ultra Receives CE Mark Approval for Stroke Treatment - Endovascular TodayRapid Medical’s Tigertriever 17 Ultra Receives CE Mark Approval for Stroke Treatment - Endovascular Today
-
Dr. Irit Yaniv liked thisDr. Irit Yaniv liked thisToday at HRX Live 2026: What comes next in AF care? This morning, Vivek Y. Reddy, MD, takes the Main Stage at the Innovation Summit to share new perspectives on the role of non-invasive, wearable neuromodulation following AF ablation. Improving AF Ablation Outcomes: Wearable Neuromodulation and the Next Frontier in AF Care 📍 Innovation Summit | Main Stage 1 🕘 Friday, Sept. 18 | 8:44–8:52 AM ET Join us at HRX Live as we explore a fundamentally different approach to addressing the remaining challenge of recurrent arrhythmia following AF ablation. #HRX2026 #AFib #Electrophysiology #Neuromodulation #WearableTech #MedTech StimCardio products are under clinical evaluation, are not FDA-cleared or approved, and are not available for sale.
-
Dr. Irit Yaniv liked thisDr. Irit Yaniv liked thisDon't miss Laminate CEO & Co-founder Tammy Gilon on the panel "Private Sector, Drivers of Care Innovation and Transformation" at the American Association of Kidney Patients Public Policy Forum tomorrow! 📅 Thursday, September 10 | 2:20 PM CT | William J. Clinton Presidential Library Join Tammy and a panel of policymakers, clinicians, and industry leaders as they discuss what it takes to move device innovation from concept to patient impact. Register here: https://hubs.li/Q04x2L980 #FortifyYourFistula
-
Dr. Irit Yaniv liked thisDr. Irit Yaniv liked thisI'm attending #LSIEurope26 in Barcelona from September 28 to October 1. If you'll be attending as well, I'd love to connect. Feel free to message me via the event app or on LinkedIn. LSI LSI Europe
-
Dr. Irit Yaniv liked thisDr. Irit Yaniv liked thisAnother first for Flexi-Port! A big congratulations to Kapil Wattamwar, MD and his team at Jersey City Medical Center for placing the first Flexi-Port in the Northeast USA. Dr. Wattamwar successfully placed 4 Flexi-Ports using the single incision technique. The single incision technique is one of the big clinical advantages of Flexi-Port and allows the physician the ability to assess each patient and make the best insertion approach. Having the ability to place the port with a single incision or a double incision, in the chest or in the arm, all while safely and easily allowing the port to self tunnel away from the incision allows for a better overall experience for both the clinician and the patient. These are just a few of the incredible advantages of the Flexi-Port innovation. Thank you, Dr. Wattamwar for your hospitality and embracing new innovation for your patients and community. We look forward to sharing your post case interview soon. Kapil Wattamwar, MD Michael Tal PorTal Access, Inc. Tonja Stevens Omer Eilon Hila Ravid
-
Dr. Irit Yaniv liked thisDr. Irit Yaniv liked thisTailorMed continues its hectic schedule at the National Association of Specialty Pharmacy (NASP) Conference in DC today as CEO Israel (Srulik) Dvorsky (r) speaks with Todd Eury of the Pharmacy Podcast Network. During the interview, Srulik shares his thoughts on how AI is reshaping patient affordability and adherence, and discusses the company’s plans to bring new solutions to market in the coming months. Jennifer Martin Bryan E. Bloom Jennifer Eaton Arielle Trzcinski Unmesh Lal Heather Landi Parallel Communications Group, Inc.
-
Dr. Irit Yaniv liked thisDr. Irit Yaniv liked thisBig milestone for portfolio company Precision Neuroscience: a $250M oversubscribed Series D, bringing total capital raised to $430M. The round was co-led by Pershing Square, the Ackman Oxman Institute, and a leading life sciences investment fund. Precision now: • leads the BCI race with 100+ patient procedures completed • built a clinical network across 18 major medical institutions • received FDA clearance for its Layer 7™ Cortical Interface • demonstrated high-resolution neural recording across 4,096 electrodes • partnered with Medtronic • built its own MEMS manufacturing capability The ambition is not simply to interface with the brain. It is to restore function for people living with severe neurological injury and disease. Congratulations to Michael Mager, Benjamin Rapoport and the entire Precision team. Great to see such a strong group of new investors joining the journey. https://lnkd.in/eDAj9yscPrecision Neuroscience Closes Oversubscribed $250M Series D Led by Pershing Square Inc., the Ackman Oxman Institute, and a Leading Life Sciences Investment FundPrecision Neuroscience Closes Oversubscribed $250M Series D Led by Pershing Square Inc., the Ackman Oxman Institute, and a Leading Life Sciences Investment Fund
Experience
Education
Patents
Other similar profiles
Explore more posts
-
Medtronic Acute Care & Monitoring
The future of anesthesia comes to Jerusalem at the Israeli Society of Anesthesiologists Conference from December 4–5. Medtronic Israel and Medasense Biometrics Ltd. will feature AI-driven NOL monitoring on-site. Prof. Philippe Richebé will lead key sessions on nociception monitoring and precision anesthesia: • 08:30 - 08:45 - Hall C: From Opioid-Induced Hyperalgesia to Opioid-Free Analgesia to Precision Anesthesia based on EEG and Nociception Monitoring • 10:00 - 10:20 - Medtronic Booth, Pitch the Crowd! NOL monitoring • 16:00 - 16:20 - Hall A: Personalized anesthesia titrated to patient need: Focus on geriatric recovery and outcomes. Let’s connect to discuss how NOL®-guided personalized anesthesia can reduce pain and medication side effects. #PatientSafety #Education #PainManagement #Anesthesia
-
I-NEXT ICHILOV
9:00 a.m., and the day looks different at Ichilov , Tel Aviv Medical Center, with four surgeries across four operating rooms, each involving the implantation of patient-specific 3D-printed implants. each with its own team, its own challenge, and its own life-changing goal. 🟦 OR A: Facial feminization surgery using patient-specific planning 🟦 OR B: Customized 3D-printed cranial implant for a young patient 🟦 OR C: Orthopedic oncology- resection of a large pelvic tumor followed by reconstruction with a titanium printed implant 🟦 OR D: Orthopedic foot & ankle- removing the talus bone and replacing it with a patient-specific 3D-printed titanium talus Over the past month, our Innovation Center teams have been working alongside the surgeons: analyzing each case, validating materials, refining the digital models, and supporting intraoperative decisions. "These cases demonstrate how surgical innovation becomes real only when technology, planning, and multidisciplinary teamwork come together." Dr. Solomin Daddia, Head of INEXT Surgical Innovation (Levin Center) We’ll update when all four procedures are completed successfully. I-NEXT | Ichilov Innovation Keren Zlotikman Shomrat Shurtz Prof. David Zeltser, MD MHA Merav Asherian Eran Golden Roi' Gilad Solomon Dadia Shimrit Arbel Amir Sternheim Assaf Albagli
1 Comment -
Schneider Children's Medical Center Research and Innovation Authority
👇 Advancing Pediatric Imaging: 👇 Successful Collaboration Between Spectrum Dynamics Medical and Schneider Children's Medical Center of Israel, Led by Dr. Zvi Bar-Sever, Director of Nuclear Medicine. We look forward to continuing our collaboration and driving further innovation together. Efrat Bron Harlev Dana Reznik Shirley Saar Moshe Phillip #NuclearMedicine #MedicalImaging #PediatricRadiology #PediatricHealthcare #MedTech #ClinicalInnovation #HealthcareInnovation
1 Comment -
Singular Genomics
We are proud to name the Spatial Technologies Unit (STU) at Beth Israel Deaconess Medical Center (BIDMC) as a G4X™ Center of Excellence! As our first Early Access site, the STU team led by Dr. Ioannis Vlachos has already validated the performance of the G4X across hundreds of FFPE samples. This designation marks the next phase of our partnership, focused on providing researchers with the workflows and expertise needed to execute large-scale spatial studies with rigor and reproducibility. Learn more: https://lnkd.in/eC8ns3D4 #SpatialBiology #PrecisionMedicine #Pathology #G4X
1 Comment
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More